{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T09:05:21Z","timestamp":1790845521299,"version":"4.1.0"},"reference-count":16,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"CSIR-CDRI Internal funds"}],"content-domain":{"domain":["clinicalkey.jp","ijaaonline.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.ijantimicag.2017.03.020","type":"journal-article","created":{"date-parts":[[2017,7,8]],"date-time":"2017-07-08T05:31:46Z","timestamp":1499491906000},"page":"389-392","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"title":["Repurposing Ivacaftor for treatment of Staphylococcus aureus infections"],"prefix":"10.1016","volume":"50","author":[{"given":"Ritesh","family":"Thakare","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4959-3869","authenticated-orcid":false,"given":"Alok Kumar","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swetarka","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Vasudevan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gorakhnath R.","family":"Jachak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. Srinivasa","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arunava","family":"Dasgupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sidharth","family":"Chopra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2017.03.020_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/595011","article-title":"Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America","volume":"48","author":"Boucher","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2017.03.020_bib0025","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/448645a","article-title":"New uses for old drugs","volume":"448","author":"Chong","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.ijantimicag.2017.03.020_bib0030","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1517\/13543784.15.11.1295","article-title":"Complementary new approaches enable repositioning of failed drug candidates","volume":"15","author":"Tartaglia","year":"2006","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.ijantimicag.2017.03.020_bib0035","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.2217\/fmb-2016-0021","article-title":"Drug repurposing: a new front in the war against Staphylococcus aureus","volume":"11","author":"Das","year":"2016","journal-title":"Future Microbiol"},{"key":"10.1016\/j.ijantimicag.2017.03.020_bib0040","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1093\/jac\/dkt045","article-title":"New drugs for methicillin-resistant Staphylococcus aureus: an update","volume":"68","author":"Kumar","year":"2013","journal-title":"J Antimicro Chemother"},{"key":"10.1016\/j.ijantimicag.2017.03.020_bib0045","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/nrd3723","article-title":"Ivacaftor","volume":"11","author":"Davis","year":"2012","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.ijantimicag.2017.03.020_bib0050","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.jcf.2014.02.004","article-title":"Antibacterial properties of the CFTR potentiator ivacaftor","volume":"13","author":"Reznikov","year":"2014","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.ijantimicag.2017.03.020_bib0055","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1021\/acsinfecdis.6b00035","article-title":"An \u2018Unlikely\u2019 Pair: the antimicrobial synergy of Polymyxin B in combination with the cystic fibrosis transmembrane conductance regulator drugs KALYDECO and ORKAMBI","volume":"2","author":"Schneider","year":"2016","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.ijantimicag.2017.03.020_bib0060","series-title":"Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically","year":"2012"},{"key":"10.1016\/j.ijantimicag.2017.03.020_bib0065","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1021\/acsmedchemlett.5b00169","article-title":"Novel chalcone-thiazole hybrids as potent inhibitors of drug resistant Staphylococcus aureus","volume":"6","author":"Sashidhara","year":"2015","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.ijantimicag.2017.03.020_bib0070","series-title":"Methods for determining bactericidal activity of antimicrobial agents; approved guideline, NCCLS document M26-A","year":"1999"},{"key":"10.1016\/j.ijantimicag.2017.03.020_bib0075","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1128\/AAC.01666-13","article-title":"Pharmacodynamics of cefquinone in a neutropenic mouse thigh model of Staphylococcus aureus infection","volume":"58","author":"Wang","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl.C","key":"10.1016\/j.ijantimicag.2017.03.020_bib0080","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/jac\/27.suppl_C.29","article-title":"Pharmacodynamics of amikacin in vitro and in mouse thigh and lung infections","volume":"27","author":"Craig","year":"1991","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2017.03.020_bib0085","author":"Drug Bank"},{"key":"10.1016\/j.ijantimicag.2017.03.020_bib0090","doi-asserted-by":"crossref","first-page":"424","DOI":"10.3390\/antibiotics4040424","article-title":"An FDA-drug library screen for compounds with bioactivities against methicillin-resistant Staphylococcus aureus (MRSA)","volume":"4","author":"Lau","year":"2015","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.ijantimicag.2017.03.020_bib0095","doi-asserted-by":"crossref","first-page":"7433","DOI":"10.1002\/ejoc.201501048","article-title":"Breaking and making of rings: a method for the preparation of 4-quinolone-3-carboxylic acid amides and the expensive drug Ivacaftor","author":"Vasudevan","year":"2015","journal-title":"Eur J Org Chem"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857917302492?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857917302492?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,30]],"date-time":"2018-08-30T08:28:47Z","timestamp":1535617727000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857917302492"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S0924857917302492"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2017.03.020","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Repurposing Ivacaftor for treatment of Staphylococcus aureus infections","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2017.03.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}]}}